Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.
about
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologistsGut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemiaAntibiotics for the treatment of irritable bowel syndromeReview article: the antimicrobial effects of rifaximin on the gut microbiota.Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-AnalysisHigh prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.Rifaximin therapy of irritable bowel syndrome.Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.Biologic properties and clinical uses of rifaximin.Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects.Rifaximin vs. conventional oral therapy for hepatic encephalopathy: a meta-analysis.A current review of the diagnostic and treatment strategies of hepatic encephalopathy.Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.Rifaximin: beyond the traditional antibiotic activity.Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles.Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.Impact of rifaximin use for hepatic encephalopathy on the risk of early post-transplant infections in liver transplant recipients.Reply: Rifampin-Resistant Staphylococcus aureus Bacteremia in a Patient on Chronic Rifaximin.A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus.Effects of rifaximin on bacterial translocation in thioacetamide-induced liver injury in rats
P2860
Q26748617-0A529D7C-A707-41A0-8849-84ACE444090CQ26826919-D1344AC7-081D-4D26-BFD4-CBFC3ED418CFQ35691133-59C6C513-9C86-4FEE-94B9-7779120346D4Q35855732-91A91664-055C-48CA-87F8-127C9C9A52E4Q35855740-5C4C2D07-1082-4BE2-A9DC-F0E7F14C6CD3Q36802060-BAC297E0-7E26-4D7A-873A-55E854C2DD7CQ37478838-DC4D759B-EBCF-477C-8588-DCE75EED3FA1Q37704526-FC02EC11-35D9-4309-96D8-33250839B890Q37768415-C4FA71C3-D728-49E9-9490-EC0A125FEDF2Q37827877-6CA6C536-2B25-458D-A037-034EED69C961Q37874146-282C79B0-7C56-4004-899B-29A562502A14Q37988849-1904CDED-EA63-429B-B2A9-7E8D4495A928Q38058329-B5E1A485-AA32-464A-9B02-470650075C61Q38066127-A7DC776F-18DD-4761-8F36-59A50562B6F5Q38237218-F9CFC980-B198-4278-BFFC-8314A2BB87F8Q39783194-483FFDD9-334C-4DD6-84CF-95DA2A547041Q41706834-D552C2F3-0D14-46EE-BA29-C6A4D1F7C296Q42407730-9037A230-876F-4967-9887-318E48B4E3B8Q48182745-48C3C817-4EF2-45FC-9ECF-E2DA9D14451BQ48711489-4AB154DD-1BED-4A71-9EB0-BBC91C0AE1D4Q49968327-809805F6-6A7E-4BBE-8D84-109CC4F147DEQ51222196-ADFCAA3A-955A-4C92-874F-9AFC72600119Q53781806-72A9ECA7-938E-4708-9D9D-640EB655E914Q57116219-2864DBE1-26BE-47E1-8D6F-C4AECC49A21B
P2860
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effects of rifaximin on bacter ...... sub-inhibitory concentrations.
@en
Effects of rifaximin on bacter ...... sub-inhibitory concentrations.
@nl
type
label
Effects of rifaximin on bacter ...... sub-inhibitory concentrations.
@en
Effects of rifaximin on bacter ...... sub-inhibitory concentrations.
@nl
prefLabel
Effects of rifaximin on bacter ...... sub-inhibitory concentrations.
@en
Effects of rifaximin on bacter ...... sub-inhibitory concentrations.
@nl
P2093
P2860
P1476
Effects of rifaximin on bacter ...... sub-inhibitory concentrations.
@en
P2093
P2860
P304
P356
10.1179/JOC.2008.20.2.186
P577
2008-04-01T00:00:00Z